Breast Cancer
News
Fulvestrant Adds Punch to Anastrozole for HR+ Breast Cancer
Major Finding: Median overall survival was 47.7 months among those randomized to combination anastrozole and fulvestrant therapy, compared with 41...
News
Doctors, Patients Disconnected on Aromatase Inhibitor Compliance
Major Finding: During their first year on adjuvant endocrine therapy, 80.5% of early-stage breast cancer patients stated that they took all or...
News
T-DM1 Supports QOL in HER2+ Metastatic Breast Cancer
Major Finding: A 5-point worsening from baseline on the FACT-B TOI occurred at a mean of 7.5 months with T-DM1, compared with 3.5 months in...
News
Metastatic Work-Up Not Needed for All N2/N3 Breast Cancers
Major Finding: There was no difference in overall survival between the N2 and N3 breast cancer groups, but those with stage IV disease had a...
Conference Coverage
Vitamin D Deficiency/Breast Cancer Link Questioned
Major Finding: Serum vitamin D levels measured before diagnosis of breast cancer showed no significant association with breast cancer risk.Data...
News
Oncotype DX Cost Effective, Challenges Breast Cancer Practice
Major Finding: A low risk score on the Oncotype DX assay was present in 59% of the nearly 14,000 patients with node-positive disease, compared...
Conference Coverage
Acupuncture Flops as Relief for Muscle Pain From Aromatase Inhibitors
Major Finding: Eight weekly sessions of real or sham acupuncture resulted in similar improvements in pain and HAQ-DI scores in postmenopausal...
Conference Coverage
Recent Diabetes Increases Breast Cancer Risk
Major Finding: Swedish breast cancer patients were 37% more likely than controls to have been diagnosed with diabetes within the previous 4 years....
News
Meta-Analysis: Pregnancy-Associated Breast Cancer Fares Poorly
Major Finding: Pregnancy-associated breast cancer is associated with a 46% increased risk of death and a 59% greater relapse risk than breast...
News
Breast Cancer Linked to Benign Thyroid Disease
Major Finding: Women with breast cancer were threefold more likely to have prevalent autoimmune thyroiditis and twice as likely to be positive for...
News
Factors Predict Contralateral Breast Cancer Risk in BRCA Carriers
Major Finding: BRCA1 or -2 mutation carriers with breast cancer diagnosed before age 41 had a 26% cumulative incidence of contralateral breast...